Director at vTv Therapeutics (VTVT) receives 6,000 stock options grant
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
vTv Therapeutics Inc. director Anne M. Phillips received a grant of options to buy 6,000 shares of Class A common stock at an exercise price of $35.08 per share. These director stock options expire on June 26, 2036 and are part of her board compensation.
The option vests on the earlier of June 26, 2027 or the date of the 2027 annual general meeting of shareholders, provided she continues serving on the board through that date. Following this grant, she holds options covering 16,860 shares directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Phillips Anne M.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Director stock option (right to buy) | 6,000 | $35.08 | $210K |
Holdings After Transaction:
Director stock option (right to buy) — 16,860 shares (Direct)
Footnotes (1)
- [object Object]
Key Figures
Option grant size: 6,000 options
Exercise price: $35.08 per share
Options after grant: 16,860 options
+2 more
5 metrics
Option grant size
6,000 options
Director stock option grant to Anne M. Phillips
Exercise price
$35.08 per share
Director stock option strike price
Options after grant
16,860 options
Total derivative securities held directly post-transaction
Option expiration
June 26, 2036
Director stock option expiration date
Vesting date
Earlier of June 26, 2027 or 2027 AGM
Subject to continued board service
Key Terms
Director stock option (right to buy), Class A Common Stock, annual general meeting of shareholders, vests, +1 more
5 terms
Director stock option (right to buy) financial
"security_title: Director stock option (right to buy)"
Class A Common Stock financial
"underlying_security_title: Class A Common Stock"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
vests financial
"The option vests on the earlier of June 26, 2027"
Grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
FAQ
What did vTv Therapeutics (VTVT) director Anne M. Phillips report on this Form 4?
Anne M. Phillips reported receiving a grant of director stock options for 6,000 shares at an exercise price of $35.08 per share. The options relate to vTv Therapeutics Class A common stock and are structured as part of her compensation for serving on the board.
What are the key terms of the vTv Therapeutics (VTVT) director stock options granted to Anne M. Phillips?
The grant covers 6,000 options with an exercise price of $35.08 per share and an expiration date of June 26, 2036. The options give the right to purchase vTv Therapeutics Class A common stock if the vesting conditions are met and she chooses to exercise.
When do Anne M. Phillips’ vTv Therapeutics (VTVT) stock options vest according to the Form 4?
The director stock option vests on the earlier of June 26, 2027 and the date of vTv Therapeutics’ 2027 annual general meeting of shareholders. Vesting is conditioned on her continued service on the board of directors through the applicable vesting date, as described in the filing.
How many vTv Therapeutics (VTVT) derivative securities does Anne M. Phillips hold after this option grant?
After receiving the 6,000 director stock options, Anne M. Phillips holds derivative securities covering 16,860 shares of Class A common stock. These holdings reflect her direct ownership of options following the reported grant, as stated in the post-transaction share balance on the Form 4.
Is the vTv Therapeutics (VTVT) Form 4 transaction an open-market stock purchase or sale?
The Form 4 reports a grant of director stock options, not an open-market purchase or sale of common shares. The transaction code is “A,” indicating a grant, award, or other acquisition of derivative securities as compensation rather than a discretionary trade in the market.